CIBC World Market’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.2M Buy
346,046
+4,035
+1% +$565K 0.08% 154
2025
Q4
$42M Buy
342,011
+97,779
+40% +$11.9M 0.07% 171
2025
Q3
$27.1M Buy
244,232
+2,720
+1% +$309K 0.05% 221
2025
Q2
$26.8M Buy
241,512
+7,433
+3% +$791K 0.05% 209
2025
Q1
$26.2M Sell
234,079
-644
-0.3% -$66.5K 0.06% 189
2024
Q4
$21.7M Sell
234,723
-64,941
-22% -$5.85M 0.05% 212
2024
Q3
$25.1M Sell
299,664
-57,317
-16% -$4.37M 0.05% 199
2024
Q2
$24.5M Buy
356,981
+157,609
+79% +$10.5M 0.06% 186
2024
Q1
$14.6M Buy
199,372
+6,717
+3% +$517K 0.03% 245
2023
Q4
$15.6M Buy
192,655
+255
+0.1% +$19.8K 0.04% 208
2023
Q3
$14.4M Buy
192,400
+12,148
+7% +$934K 0.05% 198
2023
Q2
$13.9M Sell
180,252
-76,969
-30% -$6.14M 0.04% 209
2023
Q1
$21.3M Buy
257,221
+983
+0.4% +$81.4K 0.07% 166
2022
Q4
$22M Sell
256,238
-1,875
-0.7% -$148K 0.08% 155
2022
Q3
$15.9M Sell
258,113
-6,576
-2% -$415K 0.06% 177
2022
Q2
$16.4M Sell
264,689
-1,305
-0.5% -$80.8K 0.06% 183
2022
Q1
$15.8M Buy
265,994
+20,725
+8% +$1.32M 0.05% 187
2021
Q4
$17.8M Sell
245,269
-77,044
-24% -$5.31M 0.05% 186
2021
Q3
$22.5M Buy
322,313
+12,943
+4% +$909K 0.07% 154
2021
Q2
$21.3M Buy
309,370
+39,655
+15% +$2.65M 0.06% 171
2021
Q1
$17.4M Sell
269,715
-19,472
-7% -$1.26M 0.05% 181
2020
Q4
$16.8M Sell
289,187
-47,974
-14% -$2.89M 0.05% 174
2020
Q3
$21.3M Buy
337,161
+11,428
+4% +$792K 0.09% 134
2020
Q2
$25.1M Buy
325,733
+23,460
+8% +$1.8M 0.11% 115
2020
Q1
$22.6M Buy
302,273
+60,865
+25% +$4.21M 0.12% 116
2019
Q4
$15.7M Buy
241,408
+35,920
+17% +$2.34M 0.06% 155
2019
Q3
$13M Buy
205,488
+9,272
+5% +$606K 0.06% 157
2019
Q2
$13.3M Sell
196,216
-9,217
-4% -$606K 0.06% 155
2019
Q1
$13.4M Sell
205,433
-79,844
-28% -$5.31M 0.06% 167
2018
Q4
$17.8M Sell
285,277
-443,290
-61% -$31M 0.09% 136
2018
Q3
$56.3M Sell
728,567
-16,168
-2% -$1.22M 0.24% 73
2018
Q2
$52.8M Sell
744,735
-37,845
-5% -$2.67M 0.23% 67
2018
Q1
$59M Buy
782,580
+128,419
+20% +$10.2M 0.24% 63
2017
Q4
$46.9M Buy
654,161
+7,378
+1% +$560K 0.21% 66
2017
Q3
$52.4M Sell
646,783
-107,801
-14% -$8.24M 0.25% 56
2017
Q2
$53.4M Sell
754,584
-207,221
-22% -$13.8M 0.23% 60
2017
Q1
$65.3M Buy
961,805
+520,144
+118% +$36.6M 0.21% 60
2016
Q4
$31.6M Buy
441,661
+268,272
+155% +$19.9M 0.11% 69
2016
Q3
$13.7M Buy
173,389
+40,661
+31% +$3.3M 0.05% 101
2016
Q2
$11.1M Sell
132,728
-55,687
-30% -$4.94M 0.05% 101
2016
Q1
$17.3M Sell
188,415
-3,637
-2% -$328K 0.08% 65
2015
Q4
$19.4M Buy
192,052
+8,493
+5% +$884K 0.1% 62
2015
Q3
$18M Sell
183,559
-20,850
-10% -$2.32M 0.09% 59
2015
Q2
$23.9M Buy
204,409
+138,174
+209% +$15.1M 0.1% 53
2015
Q1
$6.5M Sell
66,235
-36,188
-35% -$3.67M 0.03% 134
2014
Q4
$9.65M Sell
102,423
-51,343
-33% -$5.31M 0.04% 86
2014
Q3
$16.4M Buy
153,766
+113,857
+285% +$11.1M 0.06% 62
2014
Q2
$3.31M Sell
39,909
-16,308
-29% -$1.27M 0.01% 208
2014
Q1
$3.98M Sell
56,217
-74,216
-57% -$5.82M 0.02% 171
2013
Q4
$9.8M Buy
130,433
+68,832
+112% +$4.79M 0.04% 71
2013
Q3
$3.87M Buy
61,601
+13,837
+29% +$827K 0.02% 146
2013
Q2
$2.45M Buy
+47,764
New +$2.49M 0.01% 181

Other funds holding GILD

CIBC World Market's GILD Position: Q1 2026 in Review

CIBC World Market increased its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, buying an estimated $565K and bringing the position to 346,046 shares worth $48.2M. The position accounts for 0.08% of the portfolio, ranked #154.

CIBC World Market first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $65.3M in Q1 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • CIBC World Market held 346,046 shares of Gilead Sciences worth $48.2M as of Q1 2026.
  • CIBC World Market bought 4,035 Gilead Sciences shares in Q1 2026, an estimated $565K.
  • Gilead Sciences made up 0.08% of CIBC World Market's portfolio in Q1 2026, its #154 holding.
  • CIBC World Market first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • CIBC World Market's Gilead Sciences position peaked at $65.3M in Q1 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.